SUPPLEMENT

Q4 2025 — Non-GAAP reconciliations

Q4 2025PDF · 15 pages169 KB
The company reports its financial results in accordance with accounting principles generally accepted in the United States
(“GAAP” or referred to herein as “reported”). To supplement our consolidated financial statements reported on a GAAP
basis, we provide the following non-GAAP financial measures: “comparable net revenues,” “comparable currency neutral
net revenues,” “organic revenues,” “comparable operating margin,” “underlying operating margin,” “comparable operating
income,” “comparable currency neutral operating income,” “comparable EPS,” “comparable currency neutral EPS,”
“comparable currency neutral EPS excluding acquisitions and divestitures,” “underlying effective tax rate,” “free cash flow,”
“free cash flow excluding the fairlife contingent consideration payment” and “net share repurchases” each of which is
defined below. Management believes these non-GAAP financial measures provide investors with additional meaningful
financial information that should be considered when assessing our underlying business performance and trends. Further,
management believes these non-GAAP financial measures also enhance investors’ ability to compare period-to-period
financial results. Non-GAAP financial measures should be viewed in addition to, and not as an alternative for, the
company’s reported results prepared in accordance with GAAP. Our non-GAAP financial measures do not represent a
comprehensive basis of accounting. Therefore, our non-GAAP financial measures may not be comparable to similarly
titled measures reported by other companies. Reconciliations of each of these non-GAAP financial measures to GAAP
information are also included below. Management uses these non-GAAP financial measures in making financial,
operating, compensation and planning decisions and in evaluating the company’s performance. Disclosing these non-
GAAP financial measures allows investors and management to view our operating results excluding the impact of items
that are not reflective of the underlying operating performance.
DEFINITIONS
• “Currency neutral operating results” are determined by dividing or multiplying, as appropriate, our current period
actual U.S. dollar operating results by the current period actual exchange rates (that include the impact of current
period currency hedging activities) to derive our current period local currency operating results. We then multiply or
divide, as appropriate, the derived current period local currency operating results by the foreign currency exchange
rates (that also include the impact of the comparable prior period currency hedging activities) used to translate the
company’s financial statements in the comparable prior year period to determine what the current period U.S. dollar
operating results would have been if the foreign currency exchange rates had not changed from the comparable
prior year period.
• “Acquisitions and divestitures” generally refers to acquisitions and divestitures of brands or businesses, some of
which the company considers to be structural changes. The impact of acquisitions and divestitures is the difference
between the change in the relevant metric and the change in what that metric would have been if we removed the
amount associated with an acquisition or a divestiture from either the current year or the prior year, as applicable.
We generally refer to acquisitions and divestitures of bottling operations as “structural changes,” which are a
component of acquisitions and divestitures and also include the impact of intercompany transactions between our
operating segments, as applicable. Typically, structural changes do not impact the company’s unit case volume on a
consolidated basis or at the geographic operating segment level. In January, February and December 2024 as well
as May 2025, the company refranchised our bottling operations in certain territories in India, and in February 2024,
the company refranchised our bottling operations in Bangladesh and the Philippines. The impact of each of these
refranchisings has been included as a structural change in our analysis of net revenues on a consolidated basis as
well as for the Bottling Investments and Asia Pacific operating segments for the three months and year ended
December 31, 2025, as applicable. Additionally, in October 2025, the company sold our finished product operations
in Nigeria. The impact of this sale has been included as a divestiture in our analysis of net revenues on a
consolidated basis as well as for the EMEA operating segment for the three months and year ended December 31,
2025.
• “Comparable net revenues” is a non-GAAP financial measure that excludes or has otherwise been adjusted for
items impacting comparability (discussed further below). “Comparable currency neutral net revenues” is a
non-GAAP financial measure that excludes or has otherwise been adjusted for items impacting comparability
(discussed further below) as well as the impact of fluctuations in foreign currency exchange rates. Management
believes the comparable net revenues (non-GAAP) growth measure and the comparable currency neutral net
revenues (non-GAAP) growth measure provide investors with useful supplemental information to enhance their
understanding of the company’s revenue performance and trends by improving their ability to compare our period-
to-period results. “Organic revenues” is a non-GAAP financial measure that excludes or has otherwise been
THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
15

-- 1 of 15 --

adjusted for the impact of acquisitions and divestitures, as applicable, and the impact of fluctuations in foreign
currency exchange rates. Management believes the organic revenue (non-GAAP) growth measure provides users
with useful supplemental information regarding the company’s ongoing revenue performance and trends by
presenting revenue growth excluding the impact of foreign exchange as well as the impact of acquisitions and
divestitures.
• “Comparable operating income” is a non-GAAP financial measure that excludes or has otherwise been adjusted for
items impacting comparability (discussed further below). “Comparable currency neutral operating income” is a non-
GAAP financial measure that excludes or has otherwise been adjusted for items impacting comparability (discussed
further below) and the impact of fluctuations in foreign currency exchange rates. “Comparable operating margin” is a
non-GAAP financial measure that excludes or has otherwise been adjusted for items impacting comparability
(discussed further below). “Underlying operating margin” is a non-GAAP financial measure that excludes or has
otherwise been adjusted for items impacting comparability (discussed further below), the impact of fluctuations in
foreign currency exchange rates, and the impact of acquisitions and divestitures, as applicable. Management uses
these non-GAAP financial measures to evaluate the company’s performance and make resource allocation
decisions. Further, management believes the comparable operating income (non-GAAP) growth measure,
comparable currency neutral operating income (non-GAAP) growth measure, comparable operating margin (non-
GAAP) measure and underlying operating margin (non-GAAP) measure enhance its ability to communicate the
underlying operating results and provide investors with useful supplemental information to enhance their
understanding of the company’s underlying business performance and trends by improving their ability to compare
our period-to-period financial results.
• “Comparable EPS,” “comparable currency neutral EPS” and “comparable currency neutral EPS excluding
acquisitions and divestitures” are non-GAAP financial measures that exclude or have otherwise been adjusted for
items impacting comparability (discussed further below). Comparable currency neutral EPS (non-GAAP) has been
adjusted for the impact of fluctuations in foreign currency exchange rates, and comparable currency neutral EPS
excluding acquisitions and divestitures (non-GAAP) has been adjusted for the impact of fluctuations in foreign
currency exchange rates and the impact of acquisitions and divestitures, as applicable. Management uses these
non-GAAP financial measures to evaluate the company’s performance and make resource allocation decisions.
Further, management believes the comparable EPS (non-GAAP), comparable currency neutral EPS (non-GAAP)
and comparable currency neutral EPS excluding acquisitions and divestitures (non-GAAP) growth measures
enhance its ability to communicate the underlying operating results and provide investors with useful supplemental
information to enhance their understanding of the company’s underlying business performance and trends by
improving their ability to compare our period-to-period financial results.
• “Underlying effective tax rate” is a non-GAAP financial measure that represents the estimated annual effective
income tax rate on income before income taxes, which excludes or has otherwise been adjusted for items impacting
comparability (discussed further below).
• "Net share repurchases” is a non-GAAP financial measure that reflects the net amount of purchases of stock for
treasury after considering proceeds from the issuances of stock and, as applicable, the net change in stock
issuance receivables (related to employee stock options exercised but not settled prior to the end of the period) and
the net change in treasury stock payables (for treasury shares repurchased but not settled prior to the end of the
period).
• “Free cash flow” is a non-GAAP financial measure that represents net cash provided by operating activities less
purchases of property, plant and equipment. “Free cash flow excluding the fairlife contingent consideration payment”
is a non-GAAP financial measure that represents net cash provided by operating activities less purchases of
property, plant and equipment and excludes the fairlife contingent consideration payment that was made in March
2025. Management uses these non-GAAP financial measures to evaluate the company’s performance and make
resource allocation decisions.
ITEMS IMPACTING COMPARABILITY
The following information is provided to give qualitative and quantitative information related to items impacting
comparability. Items impacting comparability are not defined terms within GAAP. Therefore, our non-GAAP financial
THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
16

-- 2 of 15 --

information may not be comparable to similarly titled measures reported by other companies. We determine which items
to consider as “items impacting comparability” based on how management views our business; makes financial,
operating, compensation and planning decisions; and evaluates the company’s ongoing performance. Items such as
charges, gains and accounting changes which are viewed by management as impacting only the current period or the
comparable period, but not both, or as pertaining to different and unrelated underlying activities or events across
comparable periods, are generally considered “items impacting comparability.” Items impacting comparability include, but
are not limited to, asset impairments, transaction gains/losses including associated costs, and charges related to
restructuring initiatives, in each case when exceeding a U.S. dollar threshold. Also included are our proportionate share of
similar items incurred by our equity method investees, timing differences related to our economic (non-designated)
hedging activities, and timing differences related to unrealized mark-to-market adjustments of equity securities and trading
debt securities, regardless of size. In addition, we provide the impact that fluctuations in foreign currency exchange rates
had on our financial results (“currency neutral operating results” defined above).
Asset Impairments
During the three months and year ended December 31, 2025, the company recorded a charge of $960 million related to
the impairment of our BODYARMOR trademark, which was primarily driven by revised projections of future operating
results, including a slowing of the projected long-term growth rate for the category, an intensifying competitive
environment, and more focused innovation and international rollout plans. Additionally, the company recorded charges of
$13 million and $44 million, respectively, related to the impairment of a trademark in Latin America, which was primarily
driven by revised projections of future operating results and changes in macroeconomic conditions. The company also
recorded a charge of $41 million related to the impairment of a trademark and property, plant and equipment in Asia
Pacific, which was primarily driven by revised projections of future operating results.
During the year ended December 31, 2025, the company recorded an other-than-temporary impairment charge of
$40 million related to an equity method investee in Latin America, which was primarily driven by revised projections of
future operating results. Additionally, the company recorded an other-than-temporary impairment charge of $25 million in
Latin America, primarily driven by the restructuring of a joint venture.
During the three months and year ended December 31, 2024, the company recorded charges of $39 million and
$126 million, respectively, related to the impairment of a trademark in Latin America, which was primarily driven by revised
projections of future operating results and changes in macroeconomic conditions.
During the year ended December 31, 2024, the company recorded a charge of $760 million related to the impairment of
our BODYARMOR trademark, which was primarily driven by revised projections of future operating results and higher
discount rates resulting from changes in macroeconomic conditions since the acquisition date. Additionally, the company
recorded an other-than-temporary impairment charge of $34 million related to an equity method investee in Latin America.
Equity Investees
During the year ended December 31, 2025, the company recorded a net charge of $21 million. During the three months
and year ended December 31, 2024, the company recorded net charges of $47 million and $92 million, respectively.
These amounts represent the company’s proportionate share of significant operating and nonoperating items recorded by
certain of our equity method investees.
Transaction Gains/Losses
During the three months and year ended December 31, 2025, the company recorded a gain of $1,952 million related to
the sale of our ownership interest in Coca-Cola Consolidated, Inc. (“Coke Consolidated”), an equity method investee, to
Coke Consolidated and a gain of $31 million related to the substantial liquidation of a joint venture in China. The company
also recorded a charge of $1,274 million related to our bottling operations in Africa that became held for sale, primarily due
to the negative net foreign currency translation adjustments that will be reclassified to income upon sale. Additionally, the
company incurred charges of $5 million and $12 million, respectively, of transactions costs related to our divestiture
activities.
THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
17

-- 3 of 15 --

During the year ended December 31, 2025, the company recorded a gain of $331 million related to the sale of a portion of
our ownership interest in Coca-Cola Europacific Partners plc, an equity method investee. The company also recognized a
gain of $102 million related to the refranchising of our bottling operations in certain territories in India. Additionally, the
company recorded a charge of $393 million related to the sale of our finished product operations in Nigeria and a charge
of $36 million related to the refranchising of certain bottling operations in Ghana. The company also recorded a charge of
$47 million related to the remeasurement of our contingent consideration liability to fair value in conjunction with our
acquisition of fairlife. In March 2025, the company made the remaining milestone payment for fairlife.
During the three months and year ended December 31, 2024, the company recorded charges of $88 million and
$3,109 million, respectively, related to the remeasurement of our contingent consideration liability to fair value in
conjunction with our acquisition of fairlife.
During the three months and year ended December 31, 2024, the company recorded gains of $13 million and
$303 million, respectively, related to the refranchising of our bottling operations in certain territories in India.
During the year ended December 31, 2024, the company recorded a gain of $595 million related to the refranchising of
our bottling operations in the Philippines. Additionally, the company recorded a gain of $506 million related to the sale of
our ownership interest in an equity method investee in Thailand and a gain of $338 million related to the sale of a portion
of our ownership interest in Coke Consolidated to Coke Consolidated. The company also recorded transactions costs
related to our divestiture activities of $9 million.
During the year ended December 31, 2024, the company recorded a gain of $6 million related to the sale of our ownership
interest in one of our equity method investees in Latin America and recorded a loss of $7 million related to post-closing
adjustments for the refranchising of our bottling operations in Vietnam in 2023.
Restructuring
During the three months and year ended December 31, 2025, the company recorded charges of $34 million and
$97 million, respectively. During the three months and year ended December 31, 2024, the company recorded charges of
$31 million and $133 million, respectively. The costs incurred were primarily related to certain initiatives designed to
further simplify and standardize our organization as part of our productivity and reinvestment program.
Other Items
Economic (Non-Designated) Hedges
The company uses derivatives as economic hedges primarily to mitigate the foreign exchange risk for certain currencies,
certain interest rate risk, and the price risk associated with the purchase of materials used in our manufacturing processes
as well as the purchase of vehicle fuel. Although these derivatives were not designated and/or did not qualify for hedge
accounting, they are effective economic hedges. The changes in fair values of these economic hedges are immediately
recognized in earnings.
The company excludes the net impact of mark-to-market adjustments for outstanding hedges and realized gains/losses
for settled hedges from our non-GAAP financial information until the period in which the underlying exposure being
hedged impacts our consolidated statement of income. Management believes this adjustment provides meaningful
information related to the impact of our economic hedging activities. During the three months and year ended
December 31, 2025, the net impact of the company’s adjustment related to our economic hedging activities resulted in
decreases of $19 million and $36 million, respectively, to our non-GAAP income before income taxes.
During the three months and year ended December 31, 2024, the net impact of the company’s adjustment related to our
economic hedging activities resulted in decreases of $162 million and $138 million, respectively, to our non-GAAP income
before income taxes.
THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
18

-- 4 of 15 --

Unrealized Gains and Losses on Equity and Trading Debt Securities
The company excludes the net impact of unrealized gains and losses resulting from mark-to-market adjustments on our
equity and trading debt securities from our non-GAAP financial information until the period in which the underlying
securities are sold and the associated gains or losses are realized, unless individually significant. Management believes
this adjustment provides meaningful information related to the impact of our investments in equity and trading debt
securities. During the three months and year ended December 31, 2025, the net impact of the company’s adjustment
related to unrealized gains and losses on our equity and trading debt securities resulted in decreases of $85 million and
$268 million, respectively, to our non-GAAP income before income taxes.
During the three months and year ended December 31, 2024, the net impact of the company’s adjustment related to
unrealized gains and losses on our equity and trading debt securities resulted in an increase of $58 million and a
decrease of $206 million, respectively, to our non-GAAP income before income taxes.
Other
During the three months and year ended December 31, 2025, the company recorded charges of $4 million and
$15 million, respectively, for the amortization of noncompete agreements related to the BODYARMOR acquisition in 2021.
The company also recorded net charges of $2 million and $10 million, respectively, related to tax litigation expense.
During the year ended December 31, 2025, the company recorded a charge of $35 million related to an indemnification
agreement entered into as a part of the refranchising of certain bottling operations. Additionally, the company recorded a
net charge of $2 million related to restructuring our manufacturing operations in the United States and a charge of
$36 million related to non-U.S. pension curtailment and special termination benefits.
During the three months and year ended December 31, 2024, the company recorded net charges of $2 million and
$19 million, respectively, related to restructuring our manufacturing operations in the United States. Additionally, the
company recorded charges of $4 million and $15 million, respectively, for the amortization of noncompete agreements
related to the BODYARMOR acquisition.
During the three months ended December 31, 2024, the company recorded a net charge of $1 million due to tax litigation
expense and during the year ended December 31, 2024, the company recorded a net benefit of $2 million related to a
revision of management’s estimates for tax litigation expense.
During the three months and year ended December 31, 2024, the company recorded a charge of $13 million related to an
indemnification agreement entered into as a part of the refranchising of certain bottling operations.
Certain Tax Matters
During the three months and year ended December 31, 2025, the company recorded net income tax benefits of
$279 million and $851 million, respectively, primarily associated with tax benefits related to completed and pending
divestitures; net changes to our unrecognized tax benefits, including interest and penalties; return to provision
adjustments; and various other discrete tax items. Additionally, the company recorded $2 million and $27 million,
respectively, of excess tax benefits associated with the company's stock-based compensation arrangements.
During the three months and year ended December 31, 2024, the company recorded $1 million and $62 million,
respectively, of excess tax benefits associated with the company’s stock-based compensation arrangements and net
income tax expense of $17 million and $50 million, respectively, primarily associated with return to provision adjustments.
The company also recorded net income tax expense of $39 million and a net income tax benefit of $2 million, respectively,
for changes to our uncertain tax positions, including interest and penalties, as well as for various discrete tax items.
Additionally, the company recorded net income tax expense of $19 million and $103 million, respectively, related to the
resolution of certain foreign tax matters and recorded expense of $2 million and $24 million, respectively, for other costs
directly related to those matters.
During the three months and year ended December 31, 2024, the company also recorded net income tax expense of
$15 million related to U.S. regulations issued during the year.
THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
19

-- 5 of 15 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
(In millions except per share data)
Three Months Ended December 31, 2025
Net
operating
revenues
Cost of
goods
sold Gross
profit Gross
margin
Selling,
general and
administrative
expenses
Other
operating
charges Operating
income Operating
margin
Reported (GAAP) $ 11,822 $ 4,723 $ 7,099 60.0% $ 4,199 $ 1,059 $ 1,841 15.6%
Items Impacting Comparability:
Asset Impairments — — — — (1,014) 1,014
Equity Investees — — — — — —
Transaction Gains/Losses — — — — (5) 5
Restructuring — — — — (34) 34
Other Items (5) 7 (12) — (6) (6)
Certain Tax Matters — — — — — —
Comparable (Non-GAAP) $ 11,817 $ 4,730 $ 7,087 60.0% $ 4,199 $ — $ 2,888 24.4%
Three Months Ended December 31, 2024
Net
operating
revenues
Cost of
goods
sold Gross
profit Gross
margin
Selling,
general and
administrative
expenses
Other
operating
charges Operating
income Operating
margin
Reported (GAAP) $ 11,544 $ 4,613 $ 6,931 60.0% $ 4,046 $ 176 $ 2,709 23.5%
Items Impacting Comparability:
Asset Impairments — — — — (39) 39
Equity Investees — — — — — —
Transaction Gains/Losses — — — — (88) 88
Restructuring — — — — (31) 31
Other Items (140) 13 (153) — (18) (135)
Certain Tax Matters — — — (2) — 2
Comparable (Non-GAAP) $ 11,404 $ 4,626 $ 6,778 59.4% $ 4,044 $ — $ 2,734 24.0%
Net
operating
revenues
Cost of
goods
sold Gross
profit
Selling,
general and
administrative
expenses
Other
operating
charges Operating
income
% Change — Reported (GAAP) 2 2 2 4 502 (32)
% Currency Impact (2) 2 (4) 2 — (13)
% Change — Currency Neutral (Non-GAAP) 4 0 6 2 — (19)
% Change — Comparable (Non-GAAP) 4 2 5 4 — 6
% Comparable Currency Impact (Non-GAAP) 0 2 (2) 2 — (8)
% Change — Comparable Currency Neutral (Non-GAAP) 4 0 7 2 — 13
Note: Certain columns may not add due to rounding. Certain growth rates may not recalculate using the rounded dollar amounts provided.
20

-- 6 of 15 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
(In millions except per share data)
Three Months Ended December 31, 2025
Interest
expense
Equity
income
(loss)
— net
Other
income
(loss)
— net
Income
before
income
taxes Income
taxes1
Effective
tax rate Net
income3
Diluted
net
income
per share
Reported (GAAP) $ 431 $ 475 $ 844 $ 2,962 $ 646 21.8% $ 2,271 $ 0.53
Items Impacting Comparability:
Asset Impairments — — — 1,014 235 779 0.18
Equity Investees — — — — 1 (1) —
Transaction Gains/Losses — — (709) (704) (503) (201) (0.05)
Restructuring — — — 34 8 26 0.01
Other Items 7 — (85) (98) (21) (77) (0.02)
Certain Tax Matters — — — — 281 (281) (0.07)
Comparable (Non-GAAP) $ 438 $ 475 $ 50 $ 3,208 $ 647 20.2% 2 $ 2,516 $ 0.58
Three Months Ended December 31, 2024
Interest
expense
Equity
income
(loss)
— net
Other
income
(loss)
— net
Income
before
income
taxes Income
taxes1
Effective
tax rate Net
income3
Diluted
net
income
per share
Reported (GAAP) $ 431 $ 338 $ (14) $ 2,806 $ 593 21.1% $ 2,195 $ 0.51
Items Impacting Comparability:
Asset Impairments — — — 39 10 29 0.01
Equity Investees — 47 — 47 — 47 0.01
Transaction Gains/Losses — — (13) 75 19 56 0.01
Restructuring — — — 31 7 24 0.01
Other Items 7 — 58 (84) (23) (61) (0.01)
Certain Tax Matters — — — 2 (89) 91 0.02
Comparable (Non-GAAP) $ 438 $ 385 $ 31 $ 2,916 $ 517 17.7% $ 2,381 $ 0.55
Interest
expense
Equity
income
(loss)
— net
Other
income
(loss)
— net
Income
before
income
taxes Income
taxes1
Net
income3
Diluted
net
income
per share
% Change — Reported (GAAP) 0 40 — 6 9 3 4
% Change — Comparable (Non-GAAP) 0 23 60 10 25 6 6
Note: Certain columns may not add due to rounding. Certain growth rates may not recalculate using the rounded dollar amounts provided.
1 The income tax adjustments are the calculated income tax benefits (charges) at the applicable tax rate for each of the items impacting comparability
with the exception of certain tax matters discussed above.
2 This does not include the impact of the ongoing tax litigation with the U.S. Internal Revenue Service, if the company were not to prevail.
3 This represents net income attributable to shareowners of The Coca-Cola Company.
21

-- 7 of 15 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
(In millions except per share data)
Year Ended December 31, 2025
Net
operating
revenues
Cost of
goods
sold Gross
profit Gross
margin
Selling,
general and
administrative
expenses
Other
operating
charges Operating
income Operating
margin
Reported (GAAP) $ 47,941 $ 18,397 $ 29,544 61.6% $ 14,521 $ 1,261 $ 13,762 28.7%
Items Impacting Comparability:
Asset Impairments — — — — (1,045) 1,045
Equity Investees — — — — — —
Transaction Gains/Losses — — — — (59) 59
Restructuring — — — — (97) 97
Other Items 121 131 (10) — (60) 50
Certain Tax Matters — — — — — —
Comparable (Non-GAAP) $ 48,062 $ 18,528 $ 29,534 61.5% $ 14,521 $ — $ 15,013 31.2%
Year Ended December 31, 2024
Net
operating
revenues
Cost of
goods
sold Gross
profit Gross
margin
Selling,
general and
administrative
expenses
Other
operating
charges Operating
income Operating
margin
Reported (GAAP) $ 47,061 $ 18,324 $ 28,737 61.1% $ 14,582 $ 4,163 $ 9,992 21.2%
Items Impacting Comparability:
Asset Impairments — — — — (886) 886
Equity Investees — — — — — —
Transaction Gains/Losses — — — — (3,118) 3,118
Restructuring — — — — (133) 133
Other Items (164) (70) (94) — (26) (68)
Certain Tax Matters — — — (24) — 24
Comparable (Non-GAAP) $ 46,897 $ 18,254 $ 28,643 61.1% $ 14,558 $ — $ 14,085 30.0%
Net
operating
revenues
Cost of
goods
sold Gross
profit
Selling,
general and
administrative
expenses
Other
operating
charges Operating
income
% Change — Reported (GAAP) 2 0 3 0 (70) 38
% Currency Impact (2) 1 (4) 0 — (12)
% Change — Currency Neutral (Non-GAAP) 4 0 7 0 — 50
% Change — Comparable (Non-GAAP) 2 1 3 0 — 7
% Comparable Currency Impact (Non-GAAP) (2) 1 (3) 0 — (7)
% Change — Comparable Currency Neutral (Non-GAAP) 4 1 6 0 — 13
Note: Certain columns may not add due to rounding. Certain growth rates may not recalculate using the rounded dollar amounts provided.
22

-- 8 of 15 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
(In millions except per share data)
Year Ended December 31, 2025
Interest
expense
Equity
income
(loss)
— net
Other
income
(loss)
— net
Income
before
income
taxes Income
taxes1
Effective
tax rate Net
income3
Diluted
net
income
per share
Reported (GAAP) $ 1,654 $ 2,031 $ 1,073 $ 15,998 $ 2,861 17.9% $ 13,107 $ 3.04
Items Impacting Comparability:
Asset Impairments — — 65 1,110 243 867 0.20
Equity Investees — 21 — 21 3 18 —
Transaction Gains/Losses — — (713) (654) (595) (66) (0.02)
Restructuring — — — 97 24 73 0.02
Other Items 25 — (231) (206) (43) (163) (0.04)
Certain Tax Matters — — — — 878 (878) (0.20)
Comparable (Non-GAAP) $ 1,679 $ 2,052 $ 194 $ 16,366 $ 3,371 20.6% 2 $ 12,958 $ 3.00
Year Ended December 31, 2024
Interest
expense
Equity
income
(loss)
— net
Other
income
(loss)
— net
Income
before
income
taxes Income
taxes1
Effective
tax rate Net
income3
Diluted
net
income
per share
Reported (GAAP) $ 1,656 $ 1,770 $ 1,992 $ 13,086 $ 2,437 18.6% $ 10,631 $ 2.46
Items Impacting Comparability:
Asset Impairments — — 34 920 222 698 0.16
Equity Investees — 92 — 92 2 90 0.02
Transaction Gains/Losses — — (1,741) 1,377 332 1,045 0.24
Restructuring — — — 133 33 100 0.02
Other Items 25 — (206) (299) (70) (229) (0.05)
Certain Tax Matters — — — 24 (104) 128 0.03
Comparable (Non-GAAP) $ 1,681 $ 1,862 $ 79 $ 15,333 $ 2,852 18.6% $ 12,463 $ 2.88
Interest
expense
Equity
income
(loss)
— net
Other
income
(loss)
— net
Income
before
income
taxes Income
taxes1
Net
income3
Diluted
net
income
per share
% Change — Reported (GAAP) 0 15 (46) 22 17 23 23
% Change — Comparable (Non-GAAP) 0 10 145 7 18 4 4
Note: Certain columns may not add due to rounding. Certain growth rates may not recalculate using the rounded dollar amounts provided.
1 The income tax adjustments are the calculated income tax benefits (charges) at the applicable tax rate for each of the items impacting comparability
with the exception of certain tax matters discussed above.
2 This does not include the impact of the ongoing tax litigation with the U.S. Internal Revenue Service, if the company were not to prevail.
3 This represents net income attributable to shareowners of The Coca-Cola Company.
23

-- 9 of 15 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
Diluted Net Income Per Share:
Three Months Ended
December 31, 2025
% Change — Reported (GAAP) 4
% Currency Impact (9)
% Change — Currency Neutral (Non-GAAP) 12
% Impact of Items Impacting Comparability (Non-GAAP) (2)
% Change — Comparable (Non-GAAP) 6
% Comparable Currency Impact (Non-GAAP) (5)
% Change — Comparable Currency Neutral (Non-GAAP) 11
Year Ended
December 31, 2025
% Change — Reported (GAAP) 23
% Currency Impact (8)
% Change — Currency Neutral (Non-GAAP) 32
% Impact of Items Impacting Comparability (Non-GAAP) 19
% Change — Comparable (Non-GAAP) 4
% Comparable Currency Impact (Non-GAAP) (5)
% Change — Comparable Currency Neutral (Non-GAAP) 9
Note: Certain columns may not add due to rounding.
24

-- 10 of 15 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
(In millions)
Net Operating Revenues by Operating Segment and Corporate:
Three Months Ended December 31, 2025
EMEA Latin
America North
America Asia
Pacific Bottling
Investments Corporate Eliminations Consolidated
Reported (GAAP) $ 2,684 $ 1,697 $ 4,943 $ 1,139 $ 1,515 $ 45 $ (201) $ 11,822
Items Impacting Comparability:
Other Items 1 (17) 3 8 — — — (5)
Comparable (Non-GAAP) $ 2,685 $ 1,680 $ 4,946 $ 1,147 $ 1,515 $ 45 $ (201) $ 11,817
Three Months Ended December 31, 2024
EMEA Latin
America North
America Asia
Pacific Bottling
Investments Corporate Eliminations Consolidated
Reported (GAAP) $ 2,571 $ 1,647 $ 4,731 $ 1,229 $ 1,551 $ 23 $ (208) $ 11,544
Items Impacting Comparability:
Other Items (30) (26) (14) (70) — — — (140)
Comparable (Non-GAAP) $ 2,541 $ 1,621 $ 4,717 $ 1,159 $ 1,551 $ 23 $ (208) $ 11,404
EMEA Latin
America North
America Asia
Pacific Bottling
Investments Corporate Eliminations Consolidated
% Change — Reported (GAAP) 4 3 4 (7) (2) 94 3 2
% Currency Impact 2 (7) 0 (8) 0 2 — (2)
% Change — Currency Neutral (Non-GAAP) 3 10 5 0 (2) 92 — 4
% Acquisitions, Divestitures and Structural
Changes (3) 0 0 0 (2) 0 — (1)
% Change — Organic Revenues (Non-GAAP) 6 10 5 0 (1) 92 — 5
% Change — Comparable (Non-GAAP) 6 4 5 (1) (2) 94 — 4
% Comparable Currency Impact (Non-GAAP) 3 (7) 0 (1) 0 2 — 0
% Change — Comparable Currency Neutral (Non-
GAAP) 3 10 5 0 (2) 92 — 4
Note: Certain columns may not add due to rounding. Certain growth rates may not recalculate using the rounded dollar amounts provided.
25

-- 11 of 15 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
(In millions)
Net Operating Revenues by Operating Segment and Corporate:
Year Ended December 31, 2025
EMEA Latin
America North
America Asia
Pacific Bottling
Investments Corporate Eliminations Consolidated
Reported (GAAP) $ 11,513 $ 6,334 $ 19,586 $ 5,638 $ 5,735 $ 144 $ (1,009) $ 47,941
Items Impacting Comparability:
Other Items 35 45 13 28 — — — 121
Comparable (Non-GAAP) $ 11,548 $ 6,379 $ 19,599 $ 5,666 $ 5,735 $ 144 $ (1,009) $ 48,062
Year Ended December 31, 2024
EMEA Latin
America North
America Asia
Pacific Bottling
Investments Corporate Eliminations Consolidated
Reported (GAAP) $ 10,958 $ 6,471 $ 18,869 $ 5,594 $ 6,223 $ 110 $ (1,164) $ 47,061
Items Impacting Comparability:
Other Items (46) (46) (14) (58) — — — (164)
Comparable (Non-GAAP) $ 10,912 $ 6,425 $ 18,855 $ 5,536 $ 6,223 $ 110 $ (1,164) $ 46,897
EMEA Latin
America North
America Asia
Pacific Bottling
Investments Corporate Eliminations Consolidated
% Change — Reported (GAAP) 5 (2) 4 1 (8) 30 13 2
% Currency Impact 0 (12) 0 (3) (2) 0 — (2)
% Change — Currency Neutral (Non-GAAP) 5 10 4 3 (5) 30 — 4
% Acquisitions, Divestitures and Structural
Changes (1) 0 0 (1) (7) 0 — (1)
% Change — Organic Revenues (Non-GAAP) 6 10 4 5 1 30 — 5
% Change — Comparable (Non-GAAP) 6 (1) 4 2 (8) 30 — 2
% Comparable Currency Impact (Non-GAAP) 1 (11) 0 (1) (2) 0 — (2)
% Change — Comparable Currency Neutral (Non-
GAAP) 5 10 4 4 (5) 30 — 4
Note: Certain columns may not add due to rounding. Certain growth rates may not recalculate using the rounded dollar amounts provided.
26

-- 12 of 15 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
(In millions)
Operating Income (Loss) by Operating Segment and Corporate:
Three Months Ended December 31, 2025
EMEA Latin
America North
America Asia
Pacific Bottling
Investments Corporate Consolidated
Reported (GAAP) $ 811 $ 984 $ 427 $ 250 $ 191 $ (822) $ 1,841
Items Impacting Comparability:
Asset Impairments — 13 960 41 — — 1,014
Transaction Gains/Losses — — — — — 5 5
Restructuring — — — — — 34 34
Other Items 1 (17) (5) 8 1 6 (6)
Certain Tax Matters — — — — — — —
Comparable (Non-GAAP) $ 812 $ 980 $ 1,382 $ 299 $ 192 $ (777) $ 2,888
Three Months Ended December 31, 2024
EMEA Latin
America North
America Asia
Pacific Bottling
Investments Corporate Consolidated
Reported (GAAP) $ 895 $ 989 $ 1,227 $ 391 $ 199 $ (992) $ 2,709
Items Impacting Comparability:
Asset Impairments — 39 — — — — 39
Transaction Gains/Losses — — — — — 88 88
Restructuring — — — — — 31 31
Other Items (34) (26) (27) (70) 3 19 (135)
Certain Tax Matters 2 — — — — — 2
Comparable (Non-GAAP) $ 863 $ 1,002 $ 1,200 $ 321 $ 202 $ (854) $ 2,734
EMEA Latin
America North
America Asia
Pacific Bottling
Investments Corporate Consolidated
% Change — Reported (GAAP) (9) 0 (65) (36) (4) 17 (32)
% Currency Impact (7) (16) (2) (22) (3) (1) (13)
% Change — Currency Neutral (Non-GAAP) (2) 15 (64) (15) (1) 18 (19)
% Impact of Items Impacting Comparability (Non-GAAP) (3) 2 (80) (29) 1 8 (38)
% Change — Comparable (Non-GAAP) (6) (2) 15 (7) (5) 9 6
% Comparable Currency Impact (Non-GAAP) (4) (15) 0 (4) (3) (1) (8)
% Change — Comparable Currency Neutral (Non-GAAP) (2) 13 15 (3) (2) 10 13
Note: Certain columns may not add due to rounding. Certain growth rates may not recalculate using the rounded dollar amounts provided.
27

-- 13 of 15 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
(In millions)
Operating Income (Loss) by Operating Segment and Corporate:
Year Ended December 31, 2025
EMEA Latin
America North
America Asia
Pacific Bottling
Investments Corporate Consolidated
Reported (GAAP) $ 4,298 $ 3,742 $ 5,070 $ 2,042 $ 426 $ (1,816) $ 13,762
Items Impacting Comparability:
Asset Impairments — 44 960 41 — — 1,045
Transaction Gains/Losses — — — — — 59 59
Restructuring — — — — — 97 97
Other Items 37 45 (120) 28 — 60 50
Certain Tax Matters — — — — — — —
Comparable (Non-GAAP) $ 4,335 $ 3,831 $ 5,910 $ 2,111 $ 426 $ (1,600) $ 15,013
Year Ended December 31, 2024
EMEA Latin
America North
America Asia
Pacific Bottling
Investments Corporate Consolidated
Reported (GAAP) $ 4,255 $ 3,792 $ 4,556 $ 2,156 $ 496 $ (5,263) $ 9,992
Items Impacting Comparability:
Asset Impairments — 126 760 — — — 886
Transaction Gains/Losses — — — — — 3,118 3,118
Restructuring — — — — — 133 133
Other Items (48) (46) 56 (58) 1 27 (68)
Certain Tax Matters 3 — — — — 21 24
Comparable (Non-GAAP) $ 4,210 $ 3,872 $ 5,372 $ 2,098 $ 497 $ (1,964) $ 14,085
EMEA Latin
America North
America Asia
Pacific Bottling
Investments Corporate Consolidated
% Change — Reported (GAAP) 1 (1) 11 (5) (14) 66 38
% Currency Impact (5) (21) (1) (8) (2) 0 (12)
% Change — Currency Neutral (Non-GAAP) 6 19 12 2 (12) 65 50
% Impact of Items Impacting Comparability (Non-GAAP) (2) 0 1 (6) 0 47 31
% Change — Comparable (Non-GAAP) 3 (1) 10 1 (14) 19 7
% Comparable Currency Impact (Non-GAAP) (4) (18) 0 (4) (2) 1 (7)
% Change — Comparable Currency Neutral (Non-GAAP) 7 17 10 5 (12) 18 13
Note: Certain columns may not add due to rounding. Certain growth rates may not recalculate using the rounded dollar amounts provided.
28

-- 14 of 15 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Reconciliation of GAAP and Non-GAAP Financial Measures
Operating Margin:
Three Months Ended
December 31, 2025 Three Months Ended
December 31, 2024 Basis Point
Growth (Decline)
Reported Operating Margin (GAAP) 15.57 % 23.47 % (790)
Items Impacting Comparability (Non-GAAP) (8.87) % (0.49) %
Comparable Operating Margin (Non-GAAP) 24.44 % 23.96 % 48
Comparable Currency Impact (Non-GAAP) (1.71) % 0.00 %
Comparable Currency Neutral Operating Margin (Non-GAAP) 26.15 % 23.96 % 219
Impact of Acquisitions and Divestitures on Comparable Currency
Neutral Operating Margin (Non-GAAP) 0.00 % (0.12) %
Underlying Operating Margin (Non-GAAP) 26.15 % 24.08 % 207
Year Ended
December 31, 2025 Year Ended
December 31, 2024 Basis Point
Growth (Decline)
Reported Operating Margin (GAAP) 28.71 % 21.23 % 748
Items Impacting Comparability (Non-GAAP) (2.53) % (8.80) %
Comparable Operating Margin (Non-GAAP) 31.24 % 30.03 % 121
Comparable Currency Impact (Non-GAAP) (1.38) % 0.00 %
Comparable Currency Neutral Operating Margin (Non-GAAP) 32.62 % 30.03 % 259
Impact of Acquisitions and Divestitures on Comparable Currency
Neutral Operating Margin (Non-GAAP) 0.01 % (0.06) %
Underlying Operating Margin (Non-GAAP) 32.61 % 30.09 % 252
Free Cash Flow (In millions):
Year Ended
December 31, 2025
Net Cash Provided by (Used in) Operating Activities (GAAP) $ 7,408
Purchases of Property, Plant and Equipment (GAAP) (2,112)
Free Cash Flow (Non-GAAP) 5,296
Plus: fairlife Contingent Consideration Payment 6,069
Free Cash Flow Excluding the fairlife Contingent Consideration Payment (Non-GAAP) $ 11,365
Net Share Repurchases (In millions):
Year Ended
December 31, 2025
Issuances of Stock (GAAP) $ 313
Purchases of Stock for Treasury (GAAP) (746)
Net Share Repurchases (Non-GAAP) $ (433)
Projected 2026 Free Cash Flow (In billions):
Year Ending
December 31, 2026
Projected GAAP Net Cash Provided by Operating Activities $ 14.4
Projected GAAP Purchases of Property, Plant and Equipment (2.2)
Projected Free Cash Flow (Non-GAAP) $ 12.2
29

-- 15 of 15 --